Samsung Electronics Switches Executive OPI Stock Bonus to Voluntary Choice

COMPANY / Reporter Paul Lee / 2026-01-13 06:15:55
삼성전자 서초사옥. (사진=연합뉴스)

 

 

[Alpha Biz= Paul Lee] Samsung Electronics has shifted its Overperformance Incentive (OPI) stock bonus program for executives from a mandatory stock receipt system to a voluntary choice model. The company also expanded the option for general employees to receive part of their performance bonuses in stock, similar to executives.

According to industry sources on Jan. 12, Samsung informed its executives that, starting this year, the previous OPI mandatory stock allocation—ranging from 50% for Senior Managers, 70% for Vice Presidents, 80% for Presidents, to 100% for Board Members—would be replaced with a flexible, opt-in system.

The original mandate aimed to strengthen accountable management amid stagnant stock prices. However, with Samsung shares more than doubling over the past year, the rule was deemed unnecessary. Shares that hovered around KRW 50,000 a year ago reached approximately KRW 130,000 as of the latest trading.

Under the new framework, executives and employees can choose to allocate 0–50% of their OPI in stock in 10% increments. Additionally, those who commit to holding their stock for one year may receive an extra 15% of the selected amount in advance. Employees can also opt to receive their performance bonuses entirely in cash, according to personal preference.

This change reflects Samsung’s effort to provide greater flexibility in compensation while maintaining incentives aligned with company performance.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

SK Hynix to Invest KRW 19 Trillion in 7th Advanced Packaging Facility in Cheongju
Samsung Securities Faces Delays in Commercial Paper Business Approval
Korea Exchange to Launch Pre- and After-Hours Trading From June
KFTC Probes Coupang Over Alleged Bundling and Market Dominance Concerns
Celltrion’s Eyecare Biosimilar Faces Mixed European Court Rulings
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS